HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zinc gluconate is an agonist of peroxisome proliferator-activated receptor-α in the epidermis.

Abstract
Peroxisome proliferator-activated receptors-α (PPARs-α) are nuclear receptors with anti-inflammatory properties. Zinc gluconate is efficient in the treatment of several inflammatory dermatoses. The aim of our work was to determine whether the modulation of PPAR-α expression and activity could be one of the mechanisms of action of zinc gluconate anti-inflammatory activity in inflammatory dermatoses. Thus, we used ex vivo skin explants incubated with lipopolysaccharide (LPS), a pro-inflammatory molecule, with or without zinc gluconate. We evaluated PPARprotein expression using immunohistochemistry, PPARDNA-binding activity using an ELISA-like technique, and PPARmRNA levels using quantitative PCR. On the one hand, we found that PPAR-α epidermal protein expression was stimulated by LPS and that LPS suppressed PPARmRNA expression, without modifying its function. On the other hand, in inflammatory LPS-stimulated explants, zinc gluconate significantly upregulated PPAR-α function and mRNA expression level, without changing its epidermal protein expression. These results suggest that zinc gluconate may be a PPAR-α agonist, which might play a role in the anti-inflammatory activity of this molecule.
AuthorsCarole Poiraud, Gaëlle Quereux, Anne-Chantal Knol, Rémy Allix, Amir Khammari, Brigitte Dreno
JournalExperimental dermatology (Exp Dermatol) Vol. 21 Issue 5 Pg. 347-51 (May 2012) ISSN: 1600-0625 [Electronic] Denmark
PMID22509831 (Publication Type: Journal Article)
Copyright© 2012 John Wiley & Sons A/S.
Chemical References
  • Gluconates
  • Lipopolysaccharides
  • PPAR alpha
  • RNA, Messenger
  • gluconic acid
Topics
  • Cells, Cultured
  • Down-Regulation (drug effects)
  • Epidermis (drug effects, metabolism)
  • Gluconates (pharmacology)
  • Humans
  • Lipopolysaccharides (adverse effects, pharmacology)
  • PPAR alpha (agonists, genetics, metabolism)
  • RNA, Messenger (metabolism)
  • Skin Diseases (chemically induced, metabolism)
  • Up-Regulation (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: